Skip to main content

Table 4 Prevalence of hereditary coagulation defects in patients with aivc and in patients with noaivc

From: Elevated risk of thrombophilia in agenesis of the vena cava as a factor for deep vein thrombosis

Characteristic Prevalence among patients with NoAIVC (n = 168) Prevalence among patients with AIVC (n = 165)* P value (NoAIVC vs. AIVC)
Percent
Gender (male) 46.4 73.9 <0.0001
Factor V Leiden 4.8 16.4 0.001
MTHFR gene mutation 3.6 12.7 0.005
Homocysteinemia 3.0 12.1 <0.0001
Prothrombin gene mutation 1.2 5.5 0.171
Lupus anticoagulant 0.6 3.6 0.053
  1. AIVC inferior vena cava agenesia. NoAIVC iliofemoral DVT with involvement of inferior vena cava without AIVC.
  2. *AIVC in this paper and in literature (n = 165).
  3. P values are for the univariate comparison between patients with NoAIVC and those with AIVC.